Conray-400: radiopaque contrast agent for infusion
Conray-400 is a radiopaque contrast agent produced by the Italian company Bracco. It is intended for use in medical institutions as an injection solution for X-ray examinations.
The international name of Conray-400 is iothalamic acid. It may also be called Vasographin or iothalamic acid, which are synonyms for this drug.
Conray-400 belongs to the pharmaceutical group of radiocontrast agents. It contains iodine, which provides a high level of x-ray contrast, which helps visualize organs and tissues in x-ray studies.
Conray-400 is available as a 60% infusion solution. This means that 100 milliliters of solution contains 60 grams of iothalamic acid.
The use of radiocontrast agents, including Conray-400, may be accompanied by a number of undesirable reactions, such as allergic reactions, nausea, vomiting and diarrhea. Before using Conray-400, it is necessary to assess the risks and benefits, and also check for the presence of allergic reactions in the patient.
Overall, Conray 400 is an important radiocontrast agent used to obtain accurate and high-quality images in medical settings. As with any other medication, you must follow all precautions and doctor's recommendations when using it.